← Back to catalogue

AccuSign® OPI card

FDA UDI

Class II (US FDA UDI)

by Princeton Biomeditech Corp.

Identity

Trade Name
AccuSign® OPI card FDA UDI
Generic Name
Opiate/opiate metabolite IVD, kit, rapid ICT, clinical FDA UDI
Device Name
AccuSign® OPI card; 35 Test kit; CE FDA UDI
Model / Reference
DOA-203-35-02 FDA UDI
Description
AccuSign® OPI card; 35 Test kit; CE FDA UDI

Identifiers

Catalog Number
DOA-203-35-02 FDA UDI
Primary DI / UDI-DI
10743816000082 FDA UDI
FDA Product Code
DJG FDA UDI
GMDN Term
Opiate/opiate metabolite IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3650 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Opiate/opiate metabolite IVD, kit, rapid ICT, clinical

AccuSign® OPI card by Princeton Biomeditech Corp. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Opiate/opiate metabolite IVD, kit, rapid ICT, clinical.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 84b03187-308c-4cd2-8d42-000c45e01137 36 fields · synced May 30, 2026